Mangalam Drugs and Organics Ltd Share Price
(MANGALAM)
₹78.2▲0.21%
as on 11:21AM, 30 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.83 % |
3 Month Return | -24.09 % |
1 Year Return | -23.38 % |
Market Stats | |
Previous Close | ₹78.04 |
Open | ₹78.92 |
Volume | 3,608.00 |
Upper Circuit | ₹93.64 |
Lower Circuit | ₹62.43 |
Market Cap | ₹123.52Cr |
P/E Ratio
12.12
PEG Ratio
1.98
Market Cap
₹123.52 Cr
P/B Ratio
1.03
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
-6.15
Mangalam Industrial Finance Ltd Hits Upper Circuit on MOU - 12 Dec, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.11% to 0.47% in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 71.7%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 169.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.30% of holdings in Mar 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 49.58% to 49.23% in Mar 2025 quarter
Price Dip
In the last 3 months, MANGALAM stock has moved down by -23.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 50.3% | 0.00 | |
Foreign Institutions | 0.47% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 49.23% | 0.00 | |
Others | 0% | 0.00 |
Mangalam Drugs and Organics Ltd in the last 5 years
Lowest (0.00x)
September 27, 2024
Today (12.12x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (21.50x)
September 30, 2024
Mangalam Drugs and Organics Ltd’s net profit jumped 158% since last year same period to ₹1.29Cr in the Q3 2024-2025. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -52.04% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2017, Mangalam Drugs and Organics Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.64%.
Read More about DividendsBearish
Neutral
Bullish
Mangalam Drugs and Organics Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹123.52 Cr | 1.54% | 0.72 | -₹10 Cr | ₹368 Cr | |
NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
Organisation | Mangalam Drugs and Organics Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Mangalam Drugs and Organics Ltd share price today stands at ₹78.2, Open: ₹78.92, Previous Close: ₹78.04, High: ₹79, Low: ₹77.58, 52 Week High: ₹144.99, 52 Week Low: ₹72.01.
Today's traded volume of Mangalam Drugs and Organics Ltd(MANGALAM) is 3,608.00.
Today's market capitalisation of Mangalam Drugs and Organics Ltd(MANGALAM) is ₹123.52Cr.
Mangalam Drugs and Organics Ltd (MANGALAM) share price is ₹78.2. It is down -46.07% from its 52 Week High price of ₹144.99
Mangalam Drugs and Organics Ltd (MANGALAM) share price is ₹78.2. It is up 8.60% from its 52 Week Low price of ₹72.01